ribociclib
novartis
['bcsm', 'natalee']
 natalee study presented at #asco23 25% reduction in risk of invasive disease recurrence 26% reduction in risk of distant recurrence consistent across subgroups good tolerance of 400mg dosing #bcsm 
Med onc @royalmarsdenNHS | @ICR_London | #gerionc #breastcancer | @SIOGorg President | @Anticancerfund Consultant | @europeancancer Inequalities Co-chair